Skip to main content
Loading

CDR3 Therapeutics

October 18, 2023
Franciscan B
Gene/Cell Therapy
The mission of CDR3 is to develop a curative stem cell gene immunotherapy, delivering chimeric antigen receptors (CARs) or T cell receptors (TCRs) to treat chronic viral infections and virus-associated cancers.
Speakers
Otto Yang - CDR3 Therapeutics